Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Vistagen Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 116 | 2 | 112 | −2 |
| Shares | 135.4M | 43.4K | 138.8M | +3.45M (+2.5%) |
| Value | $167.8M | $54.0K | $122.1M | −$45.7M (−27.2%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MAI Capital Management | 2,661,398 | $2.34M | 0.05% |
| Soleus Capital Management, L.P. | 825,000 | $726.0K | 0.12% |
| UBS Oconnor LLC | 381,500 | $336.0K | 0.00% |
| Assenagon Asset Management S.A. | 360,475 | $317.0K | 0.00% |
| Caption Management, LLC | 337,500 | $297.0K | 0.03% |
| HAP Trading, LLC | 331,587 | $292.0K | 0.04% |
| Group One Trading, L.P. | 135,844 | $120.0K | 0.00% |
| Belvedere Trading LLC | 138,385 | $112.0K | 0.12% |
| Simplex Trading, LLC | 48,514 | $42.0K | 0.00% |
| United Bank | 37,940 | $33.0K | 0.00% |
| Ergoteles LLC | 29,500 | $26.0K | 0.00% |
| Pinz Capital Management, LP | 19,000 | $17.0K | 0.01% |
| Xponance, Inc. | 10,552 | $9.00K | 0.00% |
| GPS Wealth Strategies Group, LLC | 7,143 | $6.00K | 0.00% |
| Selective Wealth Management, Inc. | 3,500 | $3.00K | 0.00% |
| Moneta Group Investment Advisors LLC | 2,273 | $2.00K | 0.00% |
| High Net Worth Advisory Group LLC | 1,950 | $2.00K | 0.00% |
| Curi Capital | 1,238 | $1.00K | 0.00% |
| Credit Suisse AG | 98 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 1,000 | $0 | 0.00% |
Sold out (22)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Norges Bank | 1,318,800 | $1.64M |
| Ghost Tree Capital, LLC | 1,315,154 | $1.63M |
| Logos Global Management LP | 1,000,000 | $1.24M |
| Ikarian Capital, LLC | 511,186 | $633.0K |
| Samsara BioCapital, LLC | 488,632 | $606.0K |
| Two Sigma Advisers, LP | 410,000 | $508.0K |
| HighVista Strategies LLC | 315,880 | $392.0K |
| ClariVest Asset Management LLC | 252,700 | $314.0K |
| State of Wisconsin Investment Board | 247,400 | $307.0K |
| Alps Advisors Inc | 212,257 | $263.0K |
| Twin Lakes Capital Management, LLC | 94,500 | $117.0K |
| Nisa Investment Advisors, LLC | 80,000 | $99.0K |
| Boothbay Fund Management, LLC | 76,351 | $95.0K |
| Jane Street Group, LLC | 58,491 | $73.0K |
| Mirabella Financial Services LLP | 30,100 | $37.0K |
| Garrison Bradford & Associates Inc | 20,000 | $25.0K |
| AQR Capital Management LLC | 19,860 | $25.0K |
| Virtu Financial LLC | 12,178 | $15.0K |
| Raymond James Financial Services Advisors, Inc. | 10,750 | $13.0K |
| AlphaCore Capital LLC | 10,000 | $12.0K |
| Aquatic Capital Management LLC | 9,900 | $12.0K |
| Russell Investments Group, Ltd. | 8,317 | $10.0K |
Not filed for Q2 2022 yet (2)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 30,350 | $38.0K |
| Parametric Portfolio Associates LLC | 13,029 | $16.0K |